SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001564590-22-008060
Filing Date
2022-03-01
Accepted
2022-03-01 16:28:32
Documents
74
Period of Report
2021-12-31

Document Format Files

Seq Description Document Type Size
1 10-K xene-10k_20211231.htm   iXBRL 10-K 3056704
2 EX-10.30 xene-ex1030_191.htm EX-10.30 26803
3 EX-23.1 xene-ex231_8.htm EX-23.1 21469
4 EX-31.1 xene-ex311_7.htm EX-31.1 19923
5 EX-31.2 xene-ex312_10.htm EX-31.2 19719
6 EX-32.1 xene-ex321_9.htm EX-32.1 11578
7 EX-32.2 xene-ex322_6.htm EX-32.2 11490
8 GRAPHIC gtydudruy2uq000001.jpg GRAPHIC 103657
9 GRAPHIC g3b3mstlpi5u000001.jpg GRAPHIC 3589
  Complete submission text file 0001564590-22-008060.txt   9287955

Data Files

Seq Description Document Type Size
10 XBRL TAXONOMY EXTENSION SCHEMA xene-20211231.xsd EX-101.SCH 58034
11 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE xene-20211231_cal.xml EX-101.CAL 51133
12 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE xene-20211231_def.xml EX-101.DEF 166270
13 XBRL TAXONOMY EXTENSION LABEL LINKBASE xene-20211231_lab.xml EX-101.LAB 475647
14 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE xene-20211231_pre.xml EX-101.PRE 340016
68 EXTRACTED XBRL INSTANCE DOCUMENT xene-10k_20211231_htm.xml XML 1339423
Mailing Address 200 - 3650 GILMORE WAY BURNABY A1 V5G 48W
Business Address 200 - 3650 GILMORE WAY BURNABY A1 V5G 48W (604) 484-3300
Xenon Pharmaceuticals Inc. (Filer) CIK: 0001582313 (see all company filings)

IRS No.: 980661854 | State of Incorp.: A1 | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 001-36687 | Film No.: 22698562
SIC: 2834 Pharmaceutical Preparations